Funding Opportunity PAR-24-198 from the NIH Guide for Grants and Contracts. This initiative is designed to promote discovery of cellular and molecular mechanisms that underlie brain blood vessels responses to passive anti-beta-amyloid immunotherapy that result in amyloid-related imaging abnormalities (ARIA). The goal is to establish an understanding of molecular mechanisms that can be targeted to protect the blood brain barrier (BBB), and thus the brain blood vessels, during therapeutic interventions that target beta-amyloid.

Funding Opportunity PAR-24-166 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

Notice NOT-GM-24-033 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-043 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-24-186 from the NIH Guide for Grants and Contracts. The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Funding Opportunity PA-24-185 from the NIH Guide for Grants and Contracts. The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Funding Opportunity PA-24-184 from the NIH Guide for Grants and Contracts. The purpose of the NIH Mentored Patient-Oriented Research Career Development Award (K23) is to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research.

Notice NOT-AI-24-037 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-039 from the NIH Guide for Grants and Contracts. This concept proposes to advance methodological rigor in NIDA-relevant research by supporting training on the responsible analyses of complex, large-scale datasets involving brain, behavioral, genomic, and socioenvironmental data through: 1. Courses for Skills Development 2. Curriculum or Methods Development

Notice NOT-NS-24-071 from the NIH Guide for Grants and Contracts

Eli Lilly and Company: At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indian... Indianapolis, Indiana

Eli Lilly and Company: At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indian... Boston, Massachusetts

GRAIL, LLC: GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of c... Raleigh, North Carolina

Gilead Sciences, Inc.: Sr Research Scientist I Oncology Bioinformatics, Research Data Science United States - California - Foster City Gilead Sciences, Inc. is a research... San Mateo, California

AbbVie: Company Description AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and addre... North Chicago, Illinois

Visterra, Inc.: Summary Visterra is seeking a highly talented, self-motivated and innovative Postdoctoral Research Fellow to join our Technology Platform team. The... Waltham, Massachusetts

AbbVie: Company Description AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and addre... North Chicago, Illinois

Notice NOT-MH-24-190 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-24-013 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-project research programs for the development, characterization, and advancement of gene- and cell-based approaches to achieve long-term remission or elimination of HIV. Approaches will eventually be evaluated in the clinic, rendered scalable and deliverable. Applications are expected to include basic science discovery as well as preclinical research activities such as test-of-concept studies in animal models. Applicants are required to include one or more private sector partner to participate in their program.

Notice NOT-OD-24-087 from the NIH Guide for Grants and Contracts